1) Kikuchi S, Kato M, Katsuyama T, et al. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter. 2006; 11: 147-51
|
|
|
2) Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008; 372: 392-7
|
|
|
3) Takenaka R, Okada H, Kato J, et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther. 2007; 25: 805-12
|
|
|
4) Ogura K, Hirata Y, Yanai A, et al. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol. 2008; 42: 279-83
|
|
|
5) Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer. 2009 May 26. [Epub ahead of print]
|
|
|
6) Mabe K, Takahashi M, Oizumi H, et al. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? World J Gastroenterol. 2009; 15: 4290-7
|
|
|
7) 日本ヘリコバクター学会ガイドライン作成委員会. 日本ヘリコバクター学会 “H. pylori感染の診断と治療のガイドライン" 2009改訂版. 日本ヘリコバクター学会誌. 2009; 10: 104-28
|
|
|
8) Wu CY, Kuo KN, Wu MS. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009 Aug 5. [Epub ahead of print]
|
|
|
9) Kim N, Park RY, Cho SI, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol. 2008; 42: 448-54
|
|
|
10) Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009; 151: 121-8
|
|
|
11) Take S, Mizuno M, Ishiki K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol. 2007; 42 Suppl 17: 21-7
|
|
|
12) Takata S, Ito M, Yoshihara M, et al. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report. J Gastroenterol Hepatol. 2007; 22: 571-6
|
|
|
13) Tashiro J, Miwa J, Tomita T, et al. Gastric cancer detected after Helicobacter pylori eradication. Dig Endosc. 2007; 19: 167-73
|
|
|
14) Shiotani A, Uedo N, Iishi H, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion. 2008; 78: 113-9
|
|
|
15) Mizoshita T, Tsukamoto T, Toyoda T, et al. Intestinal phenotypes of stomach cancers arising after Helicobacter pylori eradication in carcinogen-treated Mongolian gerbils. Asian Pac J Cancer Prev. 2007; 8: 267-71
|
|
|
16) Watari J, Das KK, Amenta PS, et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol. 2008; 6: 409-17
|
|
|
17) Ohara T, Kasanuki J, Ohara H, et al. Analysis of the differences in structural chromosomal aberrations of the gastric mucosa between H. pylori positive and negative gastric cancer patients: involvement of H. pylori in the onset of gastric cancer and examination of the mechanism in gastric carcinogenesis following H. pylori eradication. Oncol Rep. 2006; 16: 1333-42
|
|
|
18) Shiotani A, Uedo N, Iishi H, et al. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia. Int J Cancer. 2007; 121: 1182-9
|
|
|
19) Lee YC, Lin JT, Wu HM, et al. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16: 875-85
|
|
|
20) Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008; 23: 351-65
|
|
|